Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.19.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.214ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.284ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.3 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.318ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
R.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ML.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.283ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.96ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.185ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.329ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.229ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.342ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.90ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.169ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.528ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.175ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.483ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.181ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.113ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.594ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.328ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.547ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.247ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.181ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used